Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

XP (XP) Stock Forecast & Price Target

XP - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 6 Wall Street analysts who have issued ratings for XP in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 3 have given a hold rating, and 3 have given a buy rating for XP.

Consensus Price Target

$24.33
23.96% Upside
High Forecast$30.00
Average Forecast$24.33
Low Forecast$19.00

According to the 6 analysts' twelve-month price targets for XP, the average price target is $24.33. The highest price target for XP is $30.00, while the lowest price target for XP is $19.00. The average price target represents a forecasted upside of 23.96% from the current price of $19.63.

TypeCurrent Forecast
9/19/23 to 9/18/24
1 Month Ago
8/20/23 to 8/19/24
3 Months Ago
6/21/23 to 6/20/24
1 Year Ago
9/19/22 to 9/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$24.33$24.33$26.86$24.57
Forecasted Upside23.96% Upside26.04% Upside24.88% Upside21.89% Upside

XP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

XP Stock vs. The Competition

TypeXPFinance CompaniesS&P 500
Consensus Rating Score
2.50
2.47
2.50
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside23.96% Upside13.78% Upside7.94% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/30/2024The Goldman Sachs Group
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$22.00 ➝ $19.00+7.83%
7/11/2024UBS Group
4 of 5 stars
T. Batista
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$30.00 ➝ $21.00+15.07%
6/17/2024Bank of America
4 of 5 stars
 Lower TargetBuy ➝ Buy$31.00 ➝ $25.00+45.52%
6/5/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$29.00 ➝ $27.00+42.18%
4/23/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$31.00 ➝ $24.00+13.69%
12/5/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$27.00 ➝ $30.00+32.22%
7/20/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$15.00 ➝ $26.00+9.15%
2/28/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$26.00 ➝ $20.00+61.81%
12/13/2022Grupo Santander
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:52 PM ET.

XP Forecast - Frequently Asked Questions

What is XP's forecast for 2024?

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for XP is $24.33, with a high forecast of $30.00 and a low forecast of $19.00.

Should I buy or sell XP stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for XP in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XP shares.

Does XP's stock price have much upside?

According to analysts, XP's stock has a predicted upside of 26.04% based on their 12-month stock forecasts.

Has XP been downgraded by Wall Street analysts recently?

Over the previous 90 days, XP's stock had 1 downgrade by analysts.

What analysts cover XP?

XP has been rated by research analysts at The Goldman Sachs Group, and UBS Group in the past 90 days.

Do Wall Street analysts like XP more than its competitors?

Analysts like XP more than other "finance" companies. The consensus rating for XP is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how XP compares to other companies.



This page (NASDAQ:XP) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners